GLP-1 & Peptide Comparisons
Editorially reviewed, evidence-based comparisons to help you arrive at your next clinician appointment with sharper questions and a clearer picture of your options. Each guide covers how the options differ, trial data, approved uses, cost, side effects, and the details that actually matter.
Use comparisons to prepare, then choose the right next step
Compare GLP-1 options
Understand approved uses, evidence, and care questions.
Start comparison ->Peptide researchSeparate evidence levels
Keep approved medications and research-only topics distinct.
Read peptide guide ->Care optionsCompare clinics
Use the clinical questions after you know what you are researching.
Open clinic finder ->Semaglutide vs tirzepatide in plain English: weight loss results, side effects, cost, approvals, and questions to ask your prescriber. Updated 2026.
Ozempic and Wegovy both contain semaglutide — but they're approved for different things and dosed differently. Here's what you need to know before choosing.
Tirzepatide is FDA-approved now. Retatrutide is a triple-receptor agonist showing 24% weight loss in trials. Here's what the data shows and whether to wait.
BPC-157 and TB-500 are the two most popular recovery peptides. Here's what each does, how they differ, and why most serious users stack them together.